Volume 31, Issue 4 (July 2020)                   Studies in Medical Sciences 2020, 31(4): 267-281 | Back to browse issues page

XML Persian Abstract Print


Associate Professor, Department of Public Administration, Postgraduate Center of Payamenoor University of Tehran-Iran (Corresponding Author) , Dr_darvish@pnu.ac.ir
Abstract:   (2470 Views)
Background & Aims: Knowledge-based businesses active in the medical and health innovative eco-system play an important role in inhibiting the Covid-19 virus outbreak crisis. The current study deals with extracting and analyzing the key aspects of medical innovative eco-system and the role of innovative intermediaries in supporting the development of these businesses.
Materials & Methods: In terms of purpose, this study is developmental – applied, in terms of data collection, it is descriptive and survey and in terms of the origin of collected data, it is a mixed study (both quantitative and qualitative).The research tool for quantitative data collection was interview and qualitative data collection tool was a questionnaire created by the researchers themselves. In qualitative part, data-based method with the Glaserian approach (emergent and spontaneous) was used and in qualitative part structural equations and SMART-PLS3 software were used. The population of this study was faculty members of university of medical science (as experts) and CEOs and personnel of knowledge-based and technology-based companies that are active in medical innovative eco-system of Western Azerbaijan province, from which a sample of 162 subjects was chosen on the basis of Cochran formula.
Results: Significance level and path coefficients of the structural model obtained from the analysis, approves the impact of ecosystem variables and developing knowledge-based businesses in controlling the Covid-19 virus outbreak crisis.
Conclusion: Meanwhile, the research results emphasize the role of universities and innovative intermediaries of medical innovative eco-system, which shows that “cultural and social” and “scientific and technological” aspects have the maximum effect in the development of knowledge-based businesses and innovative actions in Covid-19 virus control.
Full-Text [PDF 4082 kb]   (781 Downloads)    
Type of Study: Qualitative | Subject: General

References
1. Mobaraki K, Ahmadzadeh J. Emerging Diseases as A Challenge for Epidemiological Transition in This Global Village. Biomed J Sci & Tech Res 2020;25(4):MS.ID.004244. [DOI:10.26717/BJSTR.2020.25.004244]
2. Aghakhani N, Mobaraki K, Ahmadzadeh J. Evidence-Based Health Policy Making: A Roadmap for Filling the Research and Decision-Making Gap. J Fam Med Dis Prev 2020;6:121. [DOI:10.23937/2469-5793/1510121]
3. Joob B, Wiwanitkit V. COVID-19 in medical personnel: observation from Thailand. J Hosp Infect 2020;104(4):453. [DOI:10.1016/j.jhin.2020.02.016] [PMID] [PMCID]
4. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020;79:104212. [DOI:10.1016/j.meegid.2020.104212] [PMID] [PMCID]
5. Chrousos GP, Mentis A-FA, Dardiotis E. Biomedical research: lessons from the last decade's crisis and austerity-stricken small countries for the current COVID-19-related crisis. Nat Med2020;26(5):644-6. [DOI:10.1038/s41591-020-0859-7] [PMID]
6. Mavi RK, Gheibdoust H, Khanfar AA, Mavi NK. Ranking factors influencing strategic management of university business incubators with ANP. Management Decision 2019; 57 (12): 3492-3510.. [DOI:10.1108/MD-06-2018-0688]
7. Barvari F. Examining The Effect Of Performance-Based Budgeting And Intellectual Capital On Organizational Innovation In Urmia University Of Medical Sciences. Studies in Medical Sciences 2018;28(11):750-8. [Google Scholar]
8. Fartash K, Elyasi M. Iran's Experience In Developing High-Tech Medical Innovations And The Path Ahead. [URL]
9. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS med 2013;10(1):e1001362. [DOI:10.1371/journal.pmed.1001362] [PMID] [PMCID]
10. Wahlster P, Goetghebeur M, Kriza C, Niederländer C, Kolominsky-Rabas P. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA). BMC Health Serv Res 2015;15(1):262. [DOI:10.1186/s12913-015-0930-0] [PMID] [PMCID]
11. de Meijer C, Wouterse B, Polder J, Koopmanschap M. The effect of population aging on health expenditure growth: a critical review. Eur J Ageing 2013;10(4):353-61. [DOI:10.1007/s10433-013-0280-x] [PMID] [PMCID]
12. Lehoux P, Roncarolo F, Rocha Oliveira R, Pacifico Silva H. Medical innovation and the sustainability of health systems: A historical perspective on technological change in health. Health Services Management Research 2016;29(4):115-23. [DOI:10.1177/0951484816670192]
13. Durst S, Poutanen P. Success factors of innovation ecosystems-Initial insights from a literature review. Co-create 2013:27-38. [Google Scholar]
14. Gauthier É. Bibliometric analysis of scientific and technological research: a user's guide to the methodology. Citeseer; 1998.
15. Ritala P, Almpanopoulou A. In defense of 'eco'in innovation ecosystem. Technovation 2017;60:39-42. [DOI:10.1016/j.technovation.2017.01.004]
16. Adner R, Feiler D. Innovation interdependence and investment choices: An experimental approach to decision making in ecosystems. Organ Sci 2018. [DOI:10.1287/orsc.2018.1242]
17. Sorenson C, Drummond M, Khan BB. Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clinicoecon Outcomes Res 2013;5:223. [DOI:10.2147/CEOR.S39634] [PMID] [PMCID]
18. Chandra A, Skinner J. Technology growth and expenditure growth in health care. J Econ Lit 2012;50(3):645-80. [DOI:10.1257/jel.50.3.645]
19. Soete L. Science, technology and innovation studies at a crossroad: SPRU as case study. Research Policy 2019;48(4):849-57. [DOI:10.1016/j.respol.2018.10.029]
20. Majava J, Leviäkangas P, Kinnunen T, Kess P, Foit D. Spatial health and life sciences business ecosystem: a case study of San Diego. European Journal of Innovation Management 2016; 19(1): 24-46. [DOI:10.1108/EJIM-01-2015-0003]
21. Dutta S, Reynoso RE, Wunsch-Vincent S, León LR, Hardman C. Creating The Future Healthy Of Medical Lives--Innovation. Global Innovation Index 2019: Creating Healthy Lives-The Future of Medical Innovation 2019:201941. [Google Scholar]
22. Cooke P. Life sciences clusters and regional science policy. Urban studies 2004;41(5-6):1113-31. [DOI:10.1080/00420980410001675814]
23. Becker B, Gassmann O. Gaining leverage effects from knowledge modes within corporate incubators. R&d Management 2006;36(1):1-16. [DOI:10.1111/j.1467-9310.2005.00411.x]
24. Moghbeli MA, Kalantari AR, Noori Hekmat S, Lorafshar E, Koushki MS, Dehnavieh R. Challenges of Health Technology Incubators in Iran: A Qualitative Study. Evidence Based Health Policy, Management and Economics 2019;3(3):222-30. [DOI:10.18502/jebhpme.v3i3.1504]
25. Brown R, Mawson S, Lee N, Peterson L. Start-up factories, transnational entrepreneurs and entrepreneurial ecosystems: unpacking the lure of start-up accelerator programmes. Econ Plann 2019;27(5):885-904. [DOI:10.1080/09654313.2019.1588858]
26. Jensen MB, Johnson B, Lorenz E, Lundvall B-Å, Lundvall B. Forms of knowledge and modes of innovation. The learning economy and the economics of hope. 2007;155. [DOI:10.1016/j.respol.2007.01.006]
27. Yang C-H, Motohashi K, Chen J-R. Are new technology-based firms located on science parks really more innovative?: Evidence from Taiwan. Research policy 2009;38(1):77-85. [DOI:10.1016/j.respol.2008.09.001]
28. Asheim B, Coenen L, Moodysson J, Vang J. Constructing knowledge-based regional advantage: implications for regional innovation policy. Int J Entrep Innov Manag 2007;7(2-5):140-55. [DOI:10.1504/IJEIM.2007.012879]
29. Salamatbakhsh M, Mobaraki K, Ahmadzadeh J. Syndromic Surveillance System for MERS-CoV as New Early Warning and Identification Approach. Risk Management and Healthcare Policy 2020;13:93. https://doi.org/10.2147/RMHP.S239984 [DOI:10.2147/RMHP.S249636] [PMID] [PMCID]
30. Mobaraki K, Salamatbakhsh M, Ahmadzadeh J. Standard expected years of life lost as a neglected index for calculating the burden of premature mortality due to Middle East respiratory syndrome. Health Secur 2019;17(5):407-9. [DOI:10.1089/hs.2019.0074] [PMID]
31. Dana'ee Fard H, Alvani S, Azar A. Methodology of Qualitative Reasearch in Management, (A comprehensive Approach). Tehran: Eshraqi Publication; 2012. [URL]
32. Schmiedel T, Vom Brocke J, Recker J. Development and validation of an instrument to measure organizational cultures' support of business process management. Information & Management 2014;51(1):43-56. [DOI:10.1016/j.im.2013.08.005]
33. Wong KK-K. Partial least squares structural equation modeling (PLS-SEM) techniques using SmartPLS. Marketing Bulletin 2013;24(1):1-32. [Google Scholar]
34. Aishima H, Salvatore A. Doubt, faith, and knowledge: the reconfiguration of the intellectual field in post‐Nasserist Cairo. J R Anthropol Inst 2009;15:S41-S56. [DOI:10.1111/j.1467-9655.2009.01541.x]
35. Heidari R, Shehni Yailagh M, Meghdari A, Alipour S. The Impact Of Social Robots Intervention On Improving The Executive Functions In Children With Autism Disorder. Urmia Med J 2019;30(9):744-53. [Google Scholar]
36. Ahmadzadeh J, Mobaraki K. Epidemiological status of the Middle East respiratory syndrome coronavirus in 2019: an update from January 1 to march 31, 2019. Int J Gen Med 2019;12:305. [DOI:10.2147/IJGM.S215396] [PMID] [PMCID]
37. Aghazadeh-Attari J, Mohebbi I, Mansorian B, Ahmadzadeh J, Mirza-Aghazadeh-Attari M, Mobaraki K, et al. Epidemiological factors and worldwide pattern of Middle East respiratory syndrome coronavirus from 2013 to 2016. Int J Gen Med 2018;11:121. [DOI:10.2147/IJGM.S160741] [PMID] [PMCID]
38. Mobaraki K, Ahmadzadeh J. An update to Middle East respiratory syndrome coronavirus and risk of a pandemic in 2019. Clin Microbiol Infect Dis 2019;50(8):42.1. [DOI:10.15761/CMID.1000153]
39. Roh C-Y, Kim S. Medical innovation and social externality. Journal of open innovation: Technology, market, and complexity 2017; 3:(1):3. [DOI:10.1186/s40852-017-0056-1]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.